RENAMED BIOLOGICS
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizes physiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island.
RENAMED BIOLOGICS
Industry:
Biotechnology Health Care Medical
Founded:
1995-01-01
Address:
Westborough, Massachusetts, United States
Country:
United States
Status:
Active
Contact:
1(508)983-6420
Total Funding:
40 M USD
Similar Organizations
MuciMed
MuciMed engages in the development of mucin proteins for the treatment of gastrointestinal disease.
Nereus Pharmaceuticals
Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.
Investors List
North Coast Technology Investors
North Coast Technology Investors investment in Venture Round - RenaMed Biologics
EDBI
EDBI investment in Venture Round - RenaMed Biologics
TSC BioVenture Capital Corporation
TSC BioVenture Capital Corporation investment in Venture Round - RenaMed Biologics
Lurie Investment Fund
Lurie Investment Fund investment in Venture Round - RenaMed Biologics
TVM Capital
TVM Capital investment in Venture Round - RenaMed Biologics
Apjohn ventures
Apjohn ventures investment in Venture Round - RenaMed Biologics
BD Venture
BD Venture investment in Venture Round - RenaMed Biologics
MDS Capital
MDS Capital investment in Venture Round - RenaMed Biologics
Merlin Biomed
Merlin Biomed investment in Venture Round - RenaMed Biologics
More informations about "RenaMed Biologics"
RenaMed Biologics - Funding, Financials, Valuation & Investors
RenaMed Biologics engages in the development of therapies for the treatment of diseases associated with compromised kidney function. New. Resources. Advanced Search. ... How …See details»
RenaMed Biologics - Products, Competitors, Financials, Employees ...
RenaMed Biologics, a University of Michigan spin-out from the late 90s, is a clinical stage cellular therapy company dedicated to the design, development, and commercialization of human cell …See details»
RenaMed Biologics Inc - Company Profile and News
RenaMed Biologics Inc. designs, develops, and commercializes integrated cell replacement systems that provide comprehensive therapy for acute and chronic renal failure patients. The …See details»
RenaMed Biologics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore RenaMed Biologics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 4 literature.See details»
RenaMed Biologics - Updates, News, Events, Signals & Triggers
Organization. RenaMed Biologics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Recent News & Activity. Edit Recent News & Activity …See details»
RenaMed Biologics, Inc. - VentureRadar
RenaMed Biologics, Inc. VentureRadar profile. Find out more about RenaMed Biologics, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. ...See details»
RenaMed Biologics and Genzyme Announce Worldwide …
Sep 30, 2005 RenaMed Biologics, Inc., formerly Nephros Therapeutics, Inc., and Genzyme Corporation announced that they have entered into a strategic collaboration to jointly develop …See details»
RenaMed Biologics and Genzyme Announce Worldwide …
RenaMed Biologics, Inc. "Genzyme is a leading medical innovator, has a strong commitment to advancing renal disease treatments, and has proven expertise in developing and …See details»
RenaMed Biologics - CB Insights
Innovate Technologies In Biological System. Innovate Technologies In Biological Systems works on drug discovery and development within the biotechnology and pharmaceutical sectors. The …See details»
RENAMED BIOLOGICS, INC. - Michigan Company
Nov 14, 2000 RENAMED BIOLOGICS, INC. RENAMED BIOLOGICS, INC. (Identification Number: 801023436) was incorporated on 11/14/2000 in Michigan. Their business is recorded …See details»
Recipharm Appoints Vikas Gupta as President of ReciBioPharm
May 3, 2023 Recipharm AB (publ) is a Sweden-based pharmaceutical company, operating as a Contract Development and Manufacturing Organization (CDMO). The Company's acivities are …See details»
A new chapter for the Biologics Manufacturing Centre
As an independent not-for-profit corporation Biologics Manufacturing Centre (BMC) Inc. operates as a contract manufacturing organization, with a public-good mandate: to respond to pandemic …See details»
Forcing Canadians to switch from life-changing drugs saves
Apr 1, 2023 The organization told Ontario officials the province was "missing" savings of $3 million each week by maintaining biologics instead of reimbursing for the use of biosimilars …See details»
RenaMed Biologics - Crunchbase
Companies like RenaMed Biologics include Nereus Pharmaceuticals, Nerium Biotechnology, and Renovar. Nerium Biotechnology San Antonio , Texas , United States 11-50 employeesSee details»
The Biologics Revolution in the Production of Drugs
Jul 12, 2016 Biologics are highly sensitive to the conditions in which they are manufactured and handled, as well as their physical environment. As such, biologics are more difficult to …See details»
RenaMed Biologics - CB Insights
Sep 21, 2006 See RenaMed Biologics funding rounds, investors, investments, exits and more. Evaluate their financials based on RenaMed Biologics's post-money valuation and revenue. …See details»
Policy Statement on the Naming of Biologic Drugs - canada.ca
There is no internationally adopted naming scheme to distinguish among biologics that, based on active ingredient, will be assigned the same International Nonproprietary Name (INN) by the …See details»
WuXi Biologics Completes First Commercial PPQ Campaign at …
14 hours ago WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that …See details»
Biotechnology Industry Organization changes name to …
Jan 4, 2016 The organization will continue to use the shortened, “BIO” name. In the more than 22 years since its founding, BIO – formerly Biotechnology Industry Organization – has united …See details»
World Health Organization confirms MHRA to continue playing …
Apr 9, 2025 The World Health Organization (WHO) ... Biological medicines, such as vaccines, are among the most important medicines available in preventing killer diseases. Increasingly, …See details»